Uniklinik TU Dresden - Herzzentrum Dresden GmbH

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-10-05	NCT06979362
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation	cardiovascular disorder, heart disorder, heart failure	Active, not recruiting	Phase 3	2026-10-01	NCT06200207
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack	Acute Myocardial Infarction (AMI); Cardiovascular Risk	Active, not recruiting	Phase 3	2026-09-09	NCT06118281
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 3	2026-08-18	NCT07567001
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-03-11	NCT06979375

Clinical trials